Position in VTRS
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$30,794,721
+$2,174,637 QoQ
Shares Held
2,279,402
-0.8% QoQ
Ownership
0.196%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Swiss National Bank holds $531,346,390 across 28 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,293,332 | $152,884,775 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,227,900 | $127,344,348 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
120,055 | $71,190,213 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
292,600 | $38,547,124 | |
| 5 | VTRS |
Viatris Inc
This page
|
2,279,402 | $30,794,721 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
983,392 | $23,532,570 | |
| 7 | ALKS |
Alkermes plc.
|
310,300 | $10,972,208 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
131,154 | $9,948,030 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,794,721 | 2,279,402 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $28,620,084 | 2,298,802 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $22,530,439 | 2,275,802 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $20,332,734 | 2,276,902 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $29,322,232 | 3,366,502 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $41,976,444 | 3,371,602 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $41,016,992 | 3,532,902 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $37,377,227 | 3,516,202 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $42,896,861 | 3,592,702 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $40,623,351 | 3,751,002 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $38,027,081 | 3,856,702 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $43,130,585 | 4,321,702 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $46,298,193 | 4,812,702 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $54,852,001 | 4,928,302 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $44,762,589 | 5,253,825 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $54,846,309 | 5,238,425 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $56,991,888 | 5,238,225 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $62,189,630 | 4,596,425 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $64,740,883 | 4,777,925 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $71,784,743 | 5,023,425 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $70,660,609 | 5,058,025 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $91,635,320 | 4,889,825 | Shares | Sole | 2021-02-05 | |
| No filing history on record for this holder in this stock. | ||||||